Fachao Zhi

Title: Innovations of Fachao Zhi in Metabolic Health

Introduction

Fachao Zhi is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the area of metabolic health. His innovative work focuses on the use of specific bacterial strains to improve metabolic syndrome.

Latest Patents

Fachao Zhi holds a patent for the "Use of Akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome." This patent outlines the use of a composition containing Akkermansia muciniphila, specifically strains AM06 and AM02, for the prevention and treatment of metabolic syndrome. The deposit numbers for these strains are CGMCC No. 22793 for AM06 and CGMCC No. 22794 for AM02. This innovative approach aims to enhance metabolic health and address the challenges associated with metabolic syndrome.

Career Highlights

Fachao Zhi is associated with Guangzhou Zhiyi Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on health care and pharmaceutical applications.

Collaborations

Fachao Zhi collaborates with notable colleagues, including Yangyang Liu and Lijun Zheng, to further his research initiatives. Their combined expertise contributes to the innovative projects at Guangzhou Zhiyi Biotechnology Co., Ltd.

Conclusion

Fachao Zhi's contributions to the field of biotechnology, particularly in improving metabolic health through innovative compositions, highlight his role as a leading inventor. His work has the potential to make a significant impact on health care solutions for metabolic syndrome.